The US Food and Drug Administration (FDA) has lifted the Risk Evaluation and Mitigation Strategy (REMS) requirements for certain medications used to treat anemia.

Adults with certain immune system conditions often require different recommendations for the vaccines they can and should receive. A new vaccine has been added to these recommendations.